Trials / Not Yet Recruiting
Not Yet RecruitingNCT07270211
MCG In Long QT Syndrome
Magnetocardiography in Long QT Syndrome: A Prospective Study of Its Clinical and Prognostic Utility
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Magnetocardiography | MCG is a non-invasive, radiation-free imaging technique that detects the magnetic field generated by the electrical activity of the heart. |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-12-08
- Last updated
- 2026-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07270211. Inclusion in this directory is not an endorsement.